A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer

A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer

Introduction: Trifluridine/tipiracil (TAS-102) and fruquintinib are novel antitumor agents for patients with refractory metastatic colorectal cancer (mCRC). We conducted a retrospective study to explore the clinical efficacy and drug toxicities of combination therapy with TAS-102 and fruquintinib in...

Full description

Bibliographic Details
Main Authors: Jiayun Zou, Yuanyuan Wang, Jiayu Xu, Jinna Li, Tianzhuo Wang, Ying Zhang, Yibo Bai
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Clinical Medicine
Subjects:
trifluridine/tipiracil
fruquintinib
metastatic colorectal cancer
combination therapy
Online Access:https://www.mdpi.com/2077-0383/13/1/57

Internet

https://www.mdpi.com/2077-0383/13/1/57

Similar Items